Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study von SALTZ, Leonard B, CLARKE, Stephen, COUTURE, Felix, SIRZEN, Florin, CASSIDY, Jim, DIAZ-RUBIO, Eduardo, SCHEITHAUER, Werner, FIGER, Arie, WONG, Ralph, KOSKI, Sheryl, LICHINITSER, Mikhail, YANG, Tsai-Shen, RIVERA, Fernando

Volltext

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer von CASSIDY, Jim, CLARKE, Stephen, COUTURE, Felix, SIRZEN, Florin, SALTZ, Leonard, DIAZ-RUBIO, Eduardo, SCHEITHAUER, Werner, FIGER, Arie, WONG, Ralph, KOSKI, Sheryl, LICHINITSER, Mikhail, YANG, Tsai-Shen, RIVERA, Fernando

Volltext

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer von García-Foncillas, Jesús, Tabernero, Josep, Élez, Elena, Aranda, Enrique, Benavides, Manuel, Camps, Carlos, Jantus-Lewintre, Eloisa, López, Rafael, Muinelo-Romay, Laura, Montagut, Clara, Antón, Antonio, López, Guillermo, Díaz-Rubio, Eduardo, Rojo, Federico, Vivancos, Ana

Volltext

First‐Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single‐Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III... von Díaz‐Rubio, Eduardo, Gómez‐España, Auxiliadora, Massutí, Bartomeu, Sastre, Javier, Abad, Albert, Valladares, Manuel, Rivera, Fernando, Safont, Maria J., Martínez de Prado, Purificación, Gallén, Manuel, González, Encarnación, Marcuello, Eugenio, Benavides, Manuel, Fernández‐Martos, Carlos, Losa, Ferrán, Escudero, Pilar, Arrivi, Antonio, Cervantes, Andrés, Dueñas, Rosario, López‐Ladrón, Amelia, Lacasta, Adelaida, Llanos, Marta, Tabernero, Jose M., Antón, Antonio, Aranda, Enrique

Volltext

SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α von Mira, Emilia, Carmona-Rodríguez, Lorena, Pérez-Villamil, Beatriz, Casas, Josefina, Fernández-Aceñero, María Jesús, Martínez-Rey, Diego, Martín-González, Paula, Heras-Murillo, Ignacio, Paz-Cabezas, Mateo, Tardáguila, Manuel, Oury, Tim D., Martín-Puig, Silvia, Lacalle, Rosa Ana, Fabriás, Gemma, Díaz-Rubio, Eduardo, Mañes, Santos

Volltext

Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findin... von Shi, Qian, de Gramont, Aimery, Grothey, Axel, Zalcberg, John, Chibaudel, Benoist, Schmoll, Hans-Joachim, Seymour, Matthew T, Adams, Richard, Saltz, Leonard, Goldberg, Richard M, Punt, Cornelis J A, Douillard, Jean-Yves, Hoff, Paulo M, Hecht, Joel Randolph, Hurwitz, Herbert, Díaz-Rubio, Eduardo, Porschen, Rainer, Tebbutt, Niall C, Fuchs, Charles, Souglakos, John, Falcone, Alfredo, Tournigand, Christophe, Kabbinavar, Fairooz F, Heinemann, Volker, Van Cutsem, Eric, Bokemeyer, Carsten, Buyse, Marc, Sargent, Daniel J

Volltext

Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer von Tabernero, Josep, Van Cutsem, Eric, Díaz-Rubio, Eduardo, Cervantes, Andrés, Humblet, Yves, André, Thierry, Van Laethem, Jean-Luc, Soulié, Patrick, Casado, Esther, Verslype, Chris, Valera, Javier Sastre, Tortora, Giampaolo, Ciardiello, Fortunato, Kisker, Oliver, de Gramont, Aimery

Volltext

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report... von DIAZ-RUBIO, Eduardo, TABERNERO, Jose, MAUREL, Joan, GONZALEZ-FLORES, Encarnacion, APARICIO, Jorge, RIVERA, Fernando, LOSA, Ferran, ARANDA, Enrique, GOMEZ-ESPANA, Auxiliadora, MASSUTI, Bartomeu, SASTRE, Javier, CHAVES, Manuel, ABAD, Alberto, CARRATO, Alfredo, QUERALT, Bernardo, REINA, Juan José

Volltext

XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal Cancer von CASSIDY, Jim, TABERNERO, Josep, SCHÖFFSKI, Patrick, SOBRERO, Alberto, VAN CUTSEM, Eric, DIAZ-RUBIO, Eduardo, TWELVES, Chris, BRUNET, René, BUTTS, Charles, CONROY, Thierry, DEBRAUD, Filippo, FIGER, Arie, GROSSMANN, Johannes, SAWADA, Noriaki

Volltext

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First‐Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the... von Sastre, Javier, Maestro, M. Luisa, Gómez‐España, Auxiliadora, Rivera, Fernando, Valladares, Manuel, Massuti, Bartomeu, Benavides, Manuel, Gallén, Manuel, Marcuello, Eugenio, Abad, Albert, Arrivi, Antonio, Fernández‐Martos, Carlos, González, Encarnación, Tabernero, Josep M., Vidaurreta, Marta, Aranda, Enrique, Díaz‐Rubio, Eduardo

Volltext

First‐Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group... von Sastre, Javier, Grávalos, Cristina, Rivera, Fernando, Massuti, Bartomeu, Valladares‐Ayerbes, Manuel, Marcuello, Eugenio, Manzano, José L., Benavides, Manuel, Hidalgo, Manuel, Díaz‐Rubio, Eduardo, Aranda, Enrique

Volltext

Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer? von Aguado, Carlos, García-Paredes, Beatriz, Sotelo, Miguel Jhonatan, Sastre, Javier, Díaz-Rubio, Eduardo

Volltext

Nasoethmoidal Intestinal‐Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti‐Epidermal Growth Factor Receptor Therapy von Cabezas‐Camarero, Santiago, de la Orden García, Virginia, García‐Barberán, Vanesa, Mediero‐Valeros, Beatriz, Subhi‐Issa, Ahmad Issa, Llovet García, Patricia, Bando‐Polaino, Inmaculada, Merino Menéndez, Salomé, Pérez‐Segura, Pedro, Díaz‐Rubio, Eduardo

Volltext

Role of cetuximab in first-line treatment of metastatic colorectal cancer von Sotelo, Miguel Jhonatan

Volltext

SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells von Carmona-Rodríguez, Lorena, Martínez-Rey, Diego, Fernández-Aceñero, Maria Jesús, González-Martín, Alicia, Paz-Cabezas, Mateo, Rodríguez-Rodríguez, Noe, Pérez-Villamil, Beatriz, Sáez, Maria Eugenia, Díaz-Rubio, Eduardo, Mira, Emilia, Mañes, Santos

Volltext

Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome von Lorca, Víctor, Rueda, Daniel, Martín-Morales, Lorena, Poves, Carmen, Fernández-Aceñero, María Jesús, Ruiz-Ponte, Clara, Llovet, Patricia, Marrupe, David, García-Barberán, Vanesa, García-Paredes, Beatriz, Pérez-Segura, Pedro, de la Hoya, Miguel, Díaz-Rubio, Eduardo, Caldés, Trinidad, Garre, Pilar

Volltext

Chemotherapy for gastric cancer von Javier Sastre Jose Angel García-Saenz Eduardo Díaz-Rubio

Volltext

Continuing Single‐Agent Bevacizumab as Maintenance Therapy After Induction XELOX (or FOLFOX) Plus Bevacizumab in First‐Line Treatment of Metastatic Colorectal Cancer von Díaz‐Rubio, Eduardo, Pietrantonio, Filippo, Braud, Filippo

Volltext

About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants von Gutiérrez‐Enríquez, Sara, Bonache, Sandra, Ruíz de Garibay, Gorka, Osorio, Ana, Santamariña, Marta, Ramón y Cajal, Teresa, Esteban‐Cardeñosa, Eva, Tenés, Anna, Yanowsky, Kira, Barroso, Alicia, Montalban, Gemma, Blanco, Ana, Cornet, Mònica, Gadea, Neus, Infante, Mar, Caldés, Trinidad, Díaz‐Rubio, Eduardo, Balmaña, Judith, Lasa, Adriana, Vega, Ana, Benítez, Javier, la Hoya, Miguel, Diez, Orland

Volltext

Capillary Electrophoresis Analysis of Conventional Splicing Assays: IARC Analytical and Clinical Classification of 31 BRCA2 Genetic Variants von de Garibay, Gorka Ruiz, Acedo, Alberto, García-Casado, Zaida, Gutiérrez-Enríquez, Sara, Tosar, Alicia, Romero, Atocha, Garre, Pilar, Llort, Gemma, Thomassen, Mads, Díez, Orland, Pérez-Segura, Pedro, Díaz-Rubio, Eduardo, Velasco, Eladio A., Caldés, Trinidad, de la Hoya, Miguel

Volltext